North America Polymerase Chain Reaction Technologies Market Size to register a growth of 5.5% CAGR

13-02-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report North America Polymerase Chain Reaction Technologies Market, published by KBV research, the North America Polymerase Chain Reaction Technologies Market would witness market growth of 5.5% CAGR during the forecast period (2018 – 2024).

The USA market would dominate the North America Polymerase Chain Reaction Technologies in Forensics Market by Country by 2024, growing at a CAGR of 4.1 % during the forecast period. The Canada market is expected to witness a CAGR of 6.1% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 6% during (2018 - 2024).

The Biotech & Pharma Companies market dominated the North America Polymerase Chain Reaction Technologies Market by End User in 2017. The Diagnostic Centers & Hospitals market is expected to witness a CAGR of 6.1% during (2018 - 2024).

The Real-Time PCR market dominated the Mexico Polymerase Chain Reaction Technologies Market by Technology in 2017, and would achieve a market value of $293.1 million by 2024, growing at a CAGR of 5.3 % during the forecast period. The Traditional PCR market is expected to witness a CAGR of 6.9% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/north-america-polymerase-chain-reaction-technologies-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.